Journal of Clinical Densitometry
Volume 11, Issue 2 , Pages 276-282, April 2008

In Vivo and In Vitro Comparison of Densitometers in the NOREPOS Study

  • Tone K. Omsland

      Affiliations

    • Institute of General Practice and Community Medicine, University of Oslo, Oslo, Norway
    • Corresponding Author InformationAddress correspondence to: Tone Kristin Omsland, Section for Preventive Medicine and Epidemiology, Institute of General Practice and Community Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.
  • ,
  • Nina Emaus

      Affiliations

    • Institute of Community Medicine, University of Tromsø, Tromsø, Norway
  • ,
  • Clara G. Gjesdal

      Affiliations

    • Department of Public Health and Primary Health Care, University of Bergen, Bergen, Norway
  • ,
  • Jan A. Falch

      Affiliations

    • Center of Endocrinology, Aker University Hospital and Faculty of Medicine, Oslo, Norway
  • ,
  • Grethe S. Tell

      Affiliations

    • Department of Public Health and Primary Health Care, University of Bergen, Bergen, Norway
  • ,
  • Lisa Forsen

      Affiliations

    • Division of Epidemiology, Norwegian Institute of Public Health, Oslo, Norway
  • ,
  • Gro K.R. Berntsen

      Affiliations

    • Institute of Community Medicine, University of Tromsø, Tromsø, Norway
  • ,
  • Haakon E. Meyer

      Affiliations

    • Institute of General Practice and Community Medicine, University of Oslo, Oslo, Norway
    • Division of Epidemiology, Norwegian Institute of Public Health, Oslo, Norway

Received 21 June 2007; received in revised form 4 October 2007; accepted 5 October 2007. published online 03 January 2008.

Abstract 

The purpose of this study was to assess the agreement of in vivo hip scans on 3 densitometers (1 GE Lunar DPX-IQ and 2 GE Lunar Prodigy scanners) and to evaluate whether the European Spine Phantom (ESP) was able to reproduce the in vivo variability. Sixteen subjects had 3 repeated scans (with repositioning) on each densitometer, and the ESP was measured on each densitometer at least 40 times. Mean differences between hip scans on the Prodigy scanners were small and insignificant, and the in vivo results were not significantly different from the in vitro results. Bland and Altman plots showed no systematic differences between the Prodigy scanners over the range of bone mineral density (BMD). On the other hand, differences between Prodigy and DPX-IQ changed systematically over the range of BMD. The ESP did not fully reproduce the in vivo difference between Prodigy and DPX-IQ. In conclusion, the ESP is a valid substitute when assessing agreement between Prodigy scanners. However, when assessing agreement between different types of scanners, substitution of in vivo with in vitro measurements should be made with caution.

Key words: Bone mineral density, calibration, DXA

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 The NOREPOS Research Group: The Core Research Group (in alphabetic order): Nina Emaus (Tromsø), Haakon E. Meyer (Oslo), Berit Schei (Nord-Trøndelag), and Grethe S. Tell (Bergen). Local collaborators (in alphabetic order): Bergen: Gjesdal CG, Tell GS; Nord-Trøndelag: Forsén L, Forsmo S, Langhammer A, Schei B; Oslo: Falch JA, Meyer HE, Søgaard AJ; Tromsø: Berntsen GKR, Emaus N, Fønnebø V, Joachimsen RM.

PII: S1094-6950(07)00211-9

doi:10.1016/j.jocd.2007.10.001

Journal of Clinical Densitometry
Volume 11, Issue 2 , Pages 276-282, April 2008